Fertility-sparing in Early-stage Cervcial Cancer: The ETERNITY Project

Outcomes of Early-stage Cervcial Cancer Patients Sheduled to Have Fertility-sparing Approach: The ETERNITY Project

Status

Not yet recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT06351228

Acronym

Eternity

Enrollment

400

Registered

2024-04-08

Start date

2024-03-30

Completion date

2024-12-31

Last updated

2024-04-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical Cancer

Brief summary

The ETERNITY project is a retrospective analysis of outcomes of patients undergoing fertility-sparing treatment for cervcial cancer. The primary aim is to report outcomes of those patients. Other aims included: 1. Evaluation about the effectiveness of different treatment modalities; 2. Evaluation of outcomes according to different stages of disease; 3. Evaluation of the impactof neoadjuvant chemotherapy in patients undergoing conservative surgery

Interventions

OTHERConization plus nodal evaluation

Conization plus nodal evaluation

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

FEMALE

Age

18 Years to 50 Years

Healthy volunteers

Inclusion criteria

* Histological confirmed cervical cancer * FIGO Stage IA1-IB3 * Fertility-sparing (conization plus nodal dissection)

Exclusion criteria

* age less than 18 yrs * age more than 50 yrs

Design outcomes

Primary

Measure	Time frame	Description
oncological outcomes	3-yrs	disease-free survival

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 6, 2026